Pharmacological Research, Vol. 25, Supplement 1, 1992

73

TUMOR INHIBITION AND EFFECTS ON HOST SURVIVAL TIME BY RUTHENIUM" AND RHODIUM" COMPLEXES WITH DIMETHYLSULPHOXIDE LIGANDS S. PACOR, G. SAVA, G. MESTRONI* , E. ALESSIO* Istituto di Farmacologja, Facoky di Farmacia e M Dipartimento di Scienze Chimiche, University di Trieste. Key words: rhodium", ruthenium"', antitumor, Lewis lung carcinoma . Cis-dichlorodiammineplatinum° (Cisplatin) represents the best achievement of antitumor chemotherapy of the last 20 years ; nevertheless, it has a number of limitations of use due to severe side-effects and to unresponsiveness of tumors with great impact for human health, such as colo-rectal tumors. The experience of last years indicates ruthenium complexes as possible alternatives (1-4) . The aim of the present investigation was that of examining a series of rutheniumiii and rhodium°' complexes, characterized by the presence of dimethylsulphoxide ligands, on the Lewis lung carcinoma of BD2F I mice model . Treatment was performed by intraperitoneal administration of 0 .1mi/lOg body weight of distilled water containing the compound freshly dissolved immediately prior to inoculation . The effects on tumor growth were determined by measuring tumor volume at the end of treatment according to the formula : A2xBxN6), [A and B are two perpendicular axes (A

Tumor inhibition and effects on host survival time by rutheniumIII and rhodiumIII complexes with dimethylsulphoxide ligands.

Pharmacological Research, Vol. 25, Supplement 1, 1992 73 TUMOR INHIBITION AND EFFECTS ON HOST SURVIVAL TIME BY RUTHENIUM" AND RHODIUM" COMPLEXES WIT...
146KB Sizes 0 Downloads 0 Views